Literature DB >> 19097179

Factors contributing to the development of restless legs syndrome in patients with Parkinson disease.

Ji E Lee1, Hae-Won Shin, Kyung S Kim, Young H Sohn.   

Abstract

Although restless legs syndrome (RLS) commonly accompanies Parkinson disease (PD), the mechanism of RLS development in PD is still unclear. We investigated the prevalence of RLS in Korean patients with PD, and the possible contributing factors to the development of RLS in those patients. Four hundred forty-seven consecutive patients with PD were interviewed and examined. Among them, 73 patients (16.3%) were diagnosed with RLS. PD patients with RLS had a longer duration of PD symptoms, more severe PD disability, a greater degree of cognitive decline, and a longer duration of antiparkinson therapy than those without RLS. Multivariate logistic regression analysis revealed that the duration of antiparkinson therapy was the most significant factor contributing to the development of RLS in patients with PD. The present results support a higher prevalence of RLS in patients with PD and suggest that long-term antiparkinson therapy, rather than PD itself, may contribute to the development of RLS.

Entities:  

Mesh:

Year:  2009        PMID: 19097179     DOI: 10.1002/mds.22410

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  31 in total

Review 1.  Restless legs syndrome: a comprehensive overview on its epidemiology, risk factors, and treatment.

Authors:  Paul Yeh; Arthur S Walters; John W Tsuang
Journal:  Sleep Breath       Date:  2011-10-26       Impact factor: 2.816

2.  TOX3 Variants Are Involved in Restless Legs Syndrome and Parkinson's Disease with Opposite Effects.

Authors:  Sadaf Mohtashami; Qin He; Jennifer A Ruskey; Sirui Zhou; Patrick A Dion; Richard P Allen; Christopher J Earley; Edward A Fon; Lan Xiong; Nicolas Dupre; Yves Dauvilliers; Guy A Rouleau; Ziv Gan-Or
Journal:  J Mol Neurosci       Date:  2018-02-05       Impact factor: 3.444

3.  Evaluating and Managing Sleep Disorders in the Parkinson's Disease Clinic.

Authors:  S Gulyani; R Salas; Z Mari; S Choi; A Mahajan; C Gamaldo
Journal:  Basal Ganglia       Date:  2016-05-27

4.  Prevalence of non-motor symptoms in young-onset versus late-onset Parkinson's disease.

Authors:  Vladana Spica; Tatjana Pekmezović; Marina Svetel; Vladimir S Kostić
Journal:  J Neurol       Date:  2012-07-22       Impact factor: 4.849

5.  A long-term prospective follow-up study of incident RLS in the course of chronic DAergic therapy in newly diagnosed untreated patients with Parkinson's disease.

Authors:  Stefano Calzetti; Monica Angelini; Anna Negrotti; Elena Marchesi; Matteo Goldoni
Journal:  J Neural Transm (Vienna)       Date:  2013-12-20       Impact factor: 3.575

Review 6.  Parkinson's disease and sleep/wake disturbances.

Authors:  Keisuke Suzuki; Masayuki Miyamoto; Tomoyuki Miyamoto; Koichi Hirata
Journal:  Curr Neurol Neurosci Rep       Date:  2015-03       Impact factor: 5.081

7.  Restless legs syndrome in multiple system atrophy.

Authors:  Imad Ghorayeb; Sandrine Dupouy; François Tison; Wassilios G Meissner
Journal:  J Neural Transm (Vienna)       Date:  2014-05-13       Impact factor: 3.575

8.  Linking restless legs syndrome with Parkinson's disease: clinical, imaging and genetic evidence.

Authors:  Tasneem Peeraully; Eng-King Tan
Journal:  Transl Neurodegener       Date:  2012-02-27       Impact factor: 8.014

9.  Sleep disturbance and cognitive disorder: epidemiological analysis in a cohort of 263 patients.

Authors:  Michele Pistacchi; Manuela Gioulis; Franco Contin; Flavio Sanson; Sandro Zambito Marsala
Journal:  Neurol Sci       Date:  2014-07-18       Impact factor: 3.307

10.  Sleep disorders in Parkinson's disease.

Authors:  Israt Jahan; Robert A Hauser; Kelly L Sullivan; Amber Miller; Theresa A Zesiewicz
Journal:  Neuropsychiatr Dis Treat       Date:  2009-11-02       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.